What is Lipoprotein?
Lipoproteins are macromolecular complexes that transport hydrophobic lipids (cholesterol and triglycerides) through the bloodstream by packaging them with proteins called apolipoproteins. 1
Structural Composition
Lipoproteins consist of a hydrophobic core surrounded by an amphipathic surface layer:
- The core contains hydrophobic triglycerides and cholesteryl esters (hundreds to thousands of molecules per particle) 1
- The surface contains amphipathic phospholipids, smaller amounts of free cholesterol, and apolipoproteins 1
- This structure allows water-insoluble lipids to be transported in the aqueous environment of blood 1
Major Lipoprotein Classes
Lipoproteins are classified by density (determined via ultracentrifugation), forming a continuum that varies in composition, size, density, and function: 1
Chylomicrons
- Transport dietary fat and cholesterol from the small intestine 1
- Contain 80-95% triglyceride by lipid composition 1
- Require apolipoprotein B48 for secretion from the intestine 1
- After triglyceride hydrolysis by lipoprotein lipase, form chylomicron remnants that are cleared by the liver 1
Very Low-Density Lipoproteins (VLDL)
- Transport endogenously synthesized triglycerides and cholesterol from the liver 1
- Require apolipoprotein B100 for hepatic secretion 1
- Metabolized to intermediate-density lipoproteins (IDL) and then to LDL 1
Low-Density Lipoproteins (LDL)
- The primary carrier of cholesterol to peripheral tissues 1
- Taken up by LDL receptors in the liver and extrahepatic tissues 1
- Can be oxidized and taken up by macrophages, forming foam cells in arterial walls—a critical step in atherosclerosis 1
- Small, dense LDL particles are more atherogenic than larger particles due to increased susceptibility to oxidation 2
High-Density Lipoproteins (HDL)
- Mediate reverse cholesterol transport from peripheral tissues back to the liver 1
- Apolipoprotein A-I is the principal protein component 3
- Acquire surface components (phospholipids, free cholesterol, C apolipoproteins) from chylomicron and VLDL hydrolysis 3
- Associated with enzymes including LCAT, paraoxonase 1, and cholesteryl ester transfer protein 3
Critical Role of Apolipoproteins
Apolipoproteins on the lipoprotein surface serve structural and regulatory functions: 1
- Apolipoprotein B100: Required for VLDL, IDL, and LDL secretion from the liver 1
- Apolipoprotein B48: Required for chylomicron secretion from the intestine 1
- Apolipoprotein A-I: Principal HDL protein, mediates reverse cholesterol transport 3
- Apolipoprotein CII: Activates lipoprotein lipase for triglyceride hydrolysis 1
- Apolipoprotein CIII: Inhibits lipoprotein lipase activity 1
- Apolipoprotein E: Facilitates hepatic clearance of chylomicron remnants 1
Clinical Significance in Cardiovascular Disease
In patients with cardiovascular disease or hyperlipidemia, lipoprotein abnormalities follow predictable patterns:
- Atherogenic dyslipidemia is characterized by hypertriglyceridemia (elevated chylomicrons and VLDL), low HDL-cholesterol, and formation of small dense LDL particles 1
- This triad (elevated triglycerides, low HDL-C, elevated LDL-C) is associated with the highest cardiovascular risk 1
- Small, dense LDL particles are associated with increased coronary artery disease risk even when total cholesterol is only slightly elevated 2
- Lower HDL-C levels lead to cholesterol accumulation and are associated with atherosclerosis and metabolic syndrome 1
Metabolic Pathways
Lipoprotein metabolism involves coordinated enzymatic processes:
- Lipoprotein lipase (LPL) hydrolyzes triglycerides in chylomicrons and VLDL in capillary beds of adipose tissue and muscle 1
- Hepatic triglyceride lipase (HTGL) facilitates hepatic clearance of remnant particles 1
- Cholesteryl ester transfer protein (CETP) transfers triglycerides from VLDL into LDL and HDL in hypertriglyceridemic states, producing small, dense particles 2
- Lecithin-cholesteryl acyltransferase (LCAT) is important for HDL maturation 1
Common Clinical Pitfall
LDL cholesterol concentration alone may be misleading in patients with small, dense LDL particles, as there will be more LDL particles for any given cholesterol concentration. 2 Non-HDL cholesterol or apolipoprotein B measurements provide better cardiovascular risk assessment in patients with elevated triglycerides. 2